Toggle Main Menu Toggle Search

Open Access padlockePrints

Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease

Lookup NU author(s): Dr Kathryn White

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Vascular growth factors play an important role in maintaining the structure and integrity of the glomerular filtration barrier. In healthy adult glomeruli, the proendothelial survival factors vascular endothelial growth factor-A (VEGF-A) and angiopoietin-1 are constitutively expressed in glomerular podocyte epithelia. We demonstrate that this milieu of vascular growth factors is altered in streptozotocin-induced type 1 diabetic mice, with decreased angiopoietin-1 levels, VEGF-A upregulation, decreased soluble VEGF receptor-1 (VEGFR1), and increased VEGFR2 phosphorylation. This was accompanied by marked albuminuria, nephromegaly, hyperfiltration, glomerular ultrastructural alterations, and aberrant angiogenesis. We subsequently hypothesized that restoration of angiopoietin-1 expression within glomeruli might ameliorate manifestations of early diabetic glomerulopathy. Podocyte-specific inducible repletion of angiopoietin-1 in diabetic mice caused a 70% reduction of albuminuria and prevented diabetes-induced glomerular endothelial cell proliferation; hyperfiltration and renal morphology were unchanged. Furthermore, angiopoietin-1 repletion in diabetic mice increased Tie-2 phosphorylation, elevated soluble VEGFR1, and was paralleled by a decrease in VEGFR2 phosphorylation and increased endothelial nitric oxide synthase Ser(1177) phosphorylation. Diabetes-induced nephrin phosphorylation was also reduced in mice with angiopoietin-1 repletion. In conclusion, targeted angiopoietin-1 therapy shows promise as a renoprotective tool in the early stages of diabetic kidney disease.


Publication metadata

Author(s): Dessapt-Baradez C, Woolf AS, White KE, Pan JQ, Huang JL, Hayward AA, Price KL, Kolatsi-Joannou M, Locatelli M, Diennet M, Webster Z, Smillie SJ, Nair V, Kretzler M, Cohen CD, Long DA, Gnudi L

Publication type: Article

Publication status: Published

Journal: Journal of the American Society of Nephrology

Year: 2014

Volume: 25

Issue: 1

Pages: 33-42

Print publication date: 01/01/2014

ISSN (print): 1046-6673

ISSN (electronic): 1533-3450

Publisher: American Society of Nephrology

URL: http://dx.doi.org/10.1681/ASN.2012121218

DOI: 10.1681/ASN.2012121218


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
EFSD/Servier
Manchester Academic Health Science Centre
KRUK Senior Non-Clinical Fellowship
Manchester Biomedical Research Centre
MRC New Investigator Award
08/0003695Diabetes UK
P30-DK081943George M. O'Brien Kidney Research Core Centre
S13745BBSRC

Share